| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.24 | 7e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.23 | 9e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |